We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLNN market cap is 55.85M. The company's latest EPS is USD -0.3855 and P/E is -1.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 174k | 234k | 107k | 269k | 108k |
| Operating Income | -9.81M | -11.67M | -10.73M | -10.34M | -9.54M |
| Net Income | -10.98M | -1.05M | -11.77M | -25.14M | -2.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 206k | 723k | 473k | 654k |
| Operating Income | -16.33M | -20.21M | -49.98M | -48.41M | -40.54M |
| Net Income | -16.16M | -19.28M | -9.74M | -29.92M | -49.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36M | 44.49M | 39.89M | 67.85M | 60.43M |
| Total Liabilities | 45.32M | 41.26M | 41.52M | 46.31M | 39.03M |
| Total Equity | -9.32M | 3.24M | -1.63M | 21.53M | 21.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.88M | 68.24M | 63.06M | 44.49M | 52.34M |
| Total Liabilities | 9.99M | 67.9M | 50.47M | 41.26M | 38.95M |
| Total Equity | -67.77M | 341k | 12.6M | 3.24M | 13.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.3M | -39.01M | -9.22M | -16.24M | -23M |
| Investing | -12.45M | -10.16M | 4.72M | 4.76M | 4.71M |
| Financing | 875k | 17.25M | 4.59M | 42.42M | 42.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.2M | -18.93M | -34.62M | -39.01M | -30.17M |
| Investing | -294k | -387k | -1.33M | -10.16M | -1.5M |
| Financing | 5.5M | 69.53M | 27.11M | 17.25M | 42.16M |
| Market Cap | 55.85M |
| Price to Earnings Ratio | -1.12 |
| Price to Sales Ratio | 84.31 |
| Price to Cash Ratio | 1.92 |
| Price to Book Ratio | 4.12 |
| Dividend Yield | - |
| Shares Outstanding | 128.43M |
| Average Volume (1 week) | 807.49k |
| Average Volume (1 Month) | 1.51M |
| 52 Week Change | -53.24% |
| 52 Week High | 1.09 |
| 52 Week Low | 0.25 |
| Spread (Intraday) | 0.04 (10.32%) |
| Company Name | Clene Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.clene.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
